M&T Bank Corp Purchases 531 Shares of Mettler-Toledo International, Inc. $MTD

M&T Bank Corp increased its position in Mettler-Toledo International, Inc. (NYSE:MTD) by 13.3% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 4,534 shares of the medical instruments supplier’s stock after purchasing an additional 531 shares during the quarter. M&T Bank Corp’s holdings in Mettler-Toledo International were worth $5,326,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the company. Bank of New York Mellon Corp grew its holdings in Mettler-Toledo International by 71.3% during the second quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock worth $1,062,257,000 after purchasing an additional 376,419 shares during the period. Norges Bank acquired a new stake in shares of Mettler-Toledo International in the second quarter valued at approximately $360,126,000. Alliancebernstein L.P. lifted its position in shares of Mettler-Toledo International by 21.6% in the first quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock valued at $837,653,000 after buying an additional 126,147 shares during the last quarter. PineStone Asset Management Inc. boosted its stake in shares of Mettler-Toledo International by 41.9% during the 2nd quarter. PineStone Asset Management Inc. now owns 334,349 shares of the medical instruments supplier’s stock worth $392,766,000 after acquiring an additional 98,737 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Mettler-Toledo International by 42.0% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 305,722 shares of the medical instruments supplier’s stock worth $361,030,000 after acquiring an additional 90,395 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Mettler-Toledo International Price Performance

MTD stock opened at $1,422.78 on Friday. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,525.17. The stock has a market capitalization of $29.07 billion, a price-to-earnings ratio of 35.48, a PEG ratio of 4.64 and a beta of 1.40. The business’s fifty day moving average price is $1,384.89 and its two-hundred day moving average price is $1,281.34.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.20% and a negative return on equity of 426.96%. The company had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $997.36 million. During the same quarter in the previous year, the business posted $10.21 earnings per share. Mettler-Toledo International’s quarterly revenue was up 7.9% on a year-over-year basis. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. Research analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Insider Activity

In other news, CFO Shawn Vadala sold 1,895 shares of the firm’s stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of $1,455.52, for a total transaction of $2,758,210.40. Following the transaction, the chief financial officer directly owned 5,288 shares of the company’s stock, valued at approximately $7,696,789.76. This trade represents a 26.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Gerry Keller sold 236 shares of Mettler-Toledo International stock in a transaction that occurred on Friday, November 21st. The shares were sold at an average price of $1,418.58, for a total transaction of $334,784.88. Following the completion of the sale, the insider owned 159 shares of the company’s stock, valued at approximately $225,554.22. The trade was a 59.75% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 19,565 shares of company stock worth $28,683,737. Insiders own 1.94% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have issued reports on MTD. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Mettler-Toledo International in a report on Monday. Stifel Nicolaus increased their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the company a “buy” rating in a research report on Monday, November 10th. Wells Fargo & Company raised their target price on shares of Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the stock an “equal weight” rating in a research note on Monday, November 10th. Morgan Stanley began coverage on shares of Mettler-Toledo International in a report on Tuesday. They set an “equal weight” rating and a $1,550.00 target price for the company. Finally, Bank of America upped their price target on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research note on Monday, September 22nd. Five investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat.com, Mettler-Toledo International currently has a consensus rating of “Hold” and an average price target of $1,419.55.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.